A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Ossium Health, Inc.
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Assiut University
Baylor College of Medicine
CTI BioPharma
University of California, San Francisco
Phoenix Children's Hospital
National Institutes of Health Clinical Center (CC)
CTI BioPharma
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Beth Israel Deaconess Medical Center
Seagen Inc.
Mashhad University of Medical Sciences
University of Colorado, Denver
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Office of Rare Diseases (ORD)